Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @RAPSphl
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RAPSphl
-
RAPSphl proslijedio/la je Tweet
Have you registered yet? 2/6
#ClinicalTrials#Transparency#Privacyhttps://twitter.com/RAPSphl/status/1215661380004696065 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
March 5 event abt MDR CER is now open for registration. Learn more and register here: https://www.raps.org/events/philadelphia-chapter--mdr-impact-on-reporting-and-core-elements-of-cer-creation …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Still time to register to hear
@DarshanTalks address privacy concerns@USciences on Feb 6https://twitter.com/RAPSphl/status/1215661380004696065 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to everyone who came out last night for
@TempleUniv RA/QA career night. That was a joint event with the NJ@RAPSorg chapter. The next PHL event is Feb 6@USciences when@DarshanTalks addresses clinical trial transparency. Register here: https://www.raps.org/events/philadelphia-chapter-clinical-trial-transparency …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great NJ-PHL
@RAPSorg mtg tonight supporting@TempleUniv RA/QA career event. Remember our next event is Feb 6 when@DarshanTalks addressed clinical trial transparency@USciences register here https://www.raps.org/events/philadelphia-chapter-clinical-trial-transparency …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Heard that
@FDAJobs has an opening right now for Consumer Safety Officers, including here in PHL. Closes in 2 dayspic.twitter.com/75UOEj5V7q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Good turnout for
@TempleUniv@RAPSorg NY/NJ PHL networking career nightpic.twitter.com/rgkXNcOGSJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RAPSphl proslijedio/la je Tweet
US Court of Appeals on Mon. will hear pharma companies challenge an HHS rule requiring drug prices in DTC ads https://www.cadc.uscourts.gov/internet/sixtyday.nsf/newcalendar?openview&term=current&count=1000&date=2020-01-13 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hear
@DarshanTalks@USciences Feb 6 address privacy issues for life sciences companies. Register today https://www.raps.org/events/philadelphia-chapter-clinical-trial-transparency …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Choi mentioned the
@US_FDA webinar is now available herehttps://www.fda.gov/medical-devices/workshops-conferences-medical-devices/webinar-accreditation-scheme-conformity-assessment-asca-pilot-program-draft-guidance-10282019 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Simon Choi of
@US_FDA addressing the local chapter about ASCA pilot guidancepic.twitter.com/4SBCqou2JM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RAPSphl proslijedio/la je Tweet
It's Election Day. Make sure you set aside some time today to vote.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Still time to join the Nov 13
@FDAcdrhIndustry ASCA guidance presentation@ReedTechLifeSci. Register today: https://www.raps.org/events/philadelphia-chapter-asca-a-new-pilot-program-from-the-fda …https://twitter.com/PhillyCooke/status/1187737196935241737 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RAPSphl proslijedio/la je Tweet
FDA coming to
@RAPSphl to discuss latest ASCA guidance on Nov 13@ReedTechLifeSci Join@FDAcdrhIndustry here: https://www.raps.org/events/philadelphia-chapter-asca-a-new-pilot-program-from-the-fda …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RAPSphl proslijedio/la je Tweet
Coming up Nov 13 at
#ReedTech in Horsham--#Rapsphl. See the link for registration details
https://twitter.com/RAPSphl/status/1186799229009874945 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Loved tonight's EU MDR presentation? Be sure to sign up now for Nov 13 mtg w
@FDAcdrhIndustry presenting on new ASCA guidance@ReedTechLifeScihttps://twitter.com/RAPSphl/status/1174698694727405568 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tonight’s
@NetworkPartner5 &@TUVSUD EU MDR presentation is just about to get underway@TempleUnivpic.twitter.com/sBvWgDUpKi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RAPSphl proslijedio/la je Tweet
Tomorrow, Network Partners and
@TUVSUD will discuss the new EU MDR requirements for medical device manufacturers at@TempleUniv. Register for this local@RAPSorg,@RAPSphl, event now- https://www.raps.org/events/raps-philadelphia-chapter-overview-of-mdr-changes-and-the-impact-outside-the-eu …#MDR#MedicalDevice#Compliancepic.twitter.com/P6GINdgCMU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RAPSphl proslijedio/la je Tweet
At
@TempleUniv on 10/22, Network Partners and@TUVSUD will discuss strategies your medical device company can use to meet the new EU MDR. Register for this local@RAPSorg chapter,@RAPSphl, event now- https://raps.org/events/raps-philadelphia-chapter-overview-of-mdr-changes-and-the-impact-outside-the-eu …#MDR#Compliance#MedicalDevicespic.twitter.com/gp6nbJLTv0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There's still time to register for next week's event
@TempleUniv on EU MDRhttps://twitter.com/NetworkPartner5/status/1182716224414912513 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.